These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31666651)
1. Effects of attachment-based compassion therapy (ABCT) on brain-derived neurotrophic factor and low-grade inflammation among fibromyalgia patients: A randomized controlled trial. Montero-Marin J; Andrés-Rodríguez L; Tops M; Luciano JV; Navarro-Gil M; Feliu-Soler A; López-Del-Hoyo Y; Garcia-Campayo J Sci Rep; 2019 Oct; 9(1):15639. PubMed ID: 31666651 [TBL] [Abstract][Full Text] [Related]
2. Immune-inflammatory pathways and clinical changes in fibromyalgia patients treated with Mindfulness-Based Stress Reduction (MBSR): A randomized, controlled clinical trial. Andrés-Rodríguez L; Borràs X; Feliu-Soler A; Pérez-Aranda A; Rozadilla-Sacanell A; Montero-Marin J; Maes M; Luciano JV Brain Behav Immun; 2019 Aug; 80():109-119. PubMed ID: 30818032 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of "Attachment-Based Compassion Therapy" in the Treatment of Fibromyalgia: A Randomized Controlled Trial. Montero-Marín J; Navarro-Gil M; Puebla-Guedea M; Luciano JV; Van Gordon W; Shonin E; García-Campayo J Front Psychiatry; 2017; 8():307. PubMed ID: 29387020 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia - A controlled cross-sectional study. Ranzolin A; Duarte AL; Bredemeier M; da Costa Neto CA; Ascoli BM; Wollenhaupt-Aguiar B; Kapczinski F; Xavier RM Cytokine; 2016 Aug; 84():25-8. PubMed ID: 27209553 [TBL] [Abstract][Full Text] [Related]
5. Mindfulness-Based Program Plus Amygdala and Insula Retraining (MAIR) for the Treatment of Women with Fibromyalgia: A Pilot Randomized Controlled Trial. Sanabria-Mazo JP; Montero-Marin J; Feliu-Soler A; Gasión V; Navarro-Gil M; Morillo-Sarto H; Colomer-Carbonell A; Borràs X; Tops M; Luciano JV; García-Campayo J J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33050630 [TBL] [Abstract][Full Text] [Related]
6. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance. Stringham NT; Holmes PV; Stringham JM Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700 [TBL] [Abstract][Full Text] [Related]
7. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182 [TBL] [Abstract][Full Text] [Related]
8. Cost-Utility of Attachment-Based Compassion Therapy (ABCT) for Fibromyalgia Compared to Relaxation: A Pilot Randomized Controlled Trial. D'Amico F; Feliu-Soler A; Montero-Marín J; Peñarrubía-María MT; Navarro-Gil M; Van Gordon W; García-Campayo J; Luciano JV J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32156065 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of mindfulness-based stress reduction and attachment-based compassion therapy for the treatment of depressive, anxious, and adjustment disorders in mental health settings: A randomized controlled trial. Collado-Navarro C; Navarro-Gil M; Pérez-Aranda A; López-Del-Hoyo Y; Garcia-Campayo J; Montero-Marin J Depress Anxiety; 2021 Nov; 38(11):1138-1151. PubMed ID: 34288280 [TBL] [Abstract][Full Text] [Related]
10. Attachment-based compassion therapy and adapted mindfulness-based stress reduction for the treatment of depressive, anxious and adjustment disorders in mental health settings: a randomised controlled clinical trial protocol. Montero-Marin J; Collado-Navarro C; Navarro-Gil M; Lopez-Montoyo A; Demarzo M; Herrera-Mercadal P; Barcelo-Soler A; Garcia-Campayo J BMJ Open; 2019 Oct; 9(10):e029909. PubMed ID: 31597650 [TBL] [Abstract][Full Text] [Related]
11. Understanding and restoring dopaminergic function in fibromyalgia patients using a mindfulness-based psychological intervention: a [18F]-DOPA PET study. Study protocol for the FIBRODOPA study-a randomized controlled trial. Ledermann K; von Känel R; Berna C; Sprott H; Burckhardt M; Jenewein J; Garland EL; Martin-Sölch C Trials; 2021 Dec; 22(1):864. PubMed ID: 35078536 [TBL] [Abstract][Full Text] [Related]
12. Fibromyalgia Impact Reduction Using Online Personal Health Informatics: Longitudinal Observational Study. Collinge W; Soltysik R; Yarnold P J Med Internet Res; 2020 Apr; 22(4):e15819. PubMed ID: 32131045 [TBL] [Abstract][Full Text] [Related]
13. Correlation between interleukin-6 levels and methadone maintenance therapy outcomes. Lu RB; Wang TY; Lee SY; Chen SL; Chang YH; See Chen P; Lin SH; Chu CH; Huang SY; Tzeng NS; Lee IH; Chin Chen K; Kuang Yang Y; Chen P; Chen SH; Hong JS Drug Alcohol Depend; 2019 Nov; 204():107516. PubMed ID: 31513981 [TBL] [Abstract][Full Text] [Related]
14. Gentle Touch Therapy, Pain Relief and Neuroplasticity at Baseline in Fibromyalgia Syndrome: A Randomized, Multicenter Trial with Six-Month Follow-Up. Salgado ASI; Takemoto MH; de Souza CFTC; Salm DC; da Rosa D; Cardoso GC; Ludtke DD; Soares SFC; Ferreira JK; Dutra AR; Szeremeta YC; Mazzardo G; Mayra J; Sheffer DDL; Caumo W; Bittencourt EB; Schleip R; Latini A; Bobinski F; Martins DF J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013137 [TBL] [Abstract][Full Text] [Related]
15. Association between brain-derived neurotrophic factor gene polymorphisms and fibromyalgia in a Korean population: a multicenter study. Park DJ; Kim SH; Nah SS; Lee JH; Kim SK; Lee YA; Hong SJ; Kim HS; Lee HS; Kim HA; Joung CI; Kim SH; Lee SS Arthritis Res Ther; 2018 Oct; 20(1):220. PubMed ID: 30285822 [TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Kauer-Sant'Anna M; Kapczinski F; Andreazza AC; Bond DJ; Lam RW; Young LT; Yatham LN Int J Neuropsychopharmacol; 2009 May; 12(4):447-58. PubMed ID: 18771602 [TBL] [Abstract][Full Text] [Related]
17. Gender influence on clinical manifestations, depressive symptoms and brain-derived neurotrophic factor (BDNF) serum levels in patients affected by fibromyalgia. Iannuccelli C; Lucchino B; Gioia C; Dolcini G; Rabasco J; Venditto T; Ioppolo F; Santilli V; Conti F; Di Franco M Clin Rheumatol; 2022 Jul; 41(7):2171-2178. PubMed ID: 35344113 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent therapy in online and outdoor format in individuals with fibromyalgia: Study protocol of a randomized, controlled trial (On&Out study). Serrat M; Ferrés S; Auer W; Almirall M; Lluch E; D'Amico F; Maes M; Lorente S; Navarrete J; Montero-Marín J; Neblett R; Nijs J; Borràs X; Luciano JV; Feliu-Soler A Front Physiol; 2022; 13():1046613. PubMed ID: 36452042 [No Abstract] [Full Text] [Related]
19. Meditation awareness training for the treatment of fibromyalgia syndrome: A randomized controlled trial. Van Gordon W; Shonin E; Dunn TJ; Garcia-Campayo J; Griffiths MD Br J Health Psychol; 2017 Feb; 22(1):186-206. PubMed ID: 27885763 [TBL] [Abstract][Full Text] [Related]
20. Plasma Cytokine Levels in Fibromyalgia and Their Response to 15 Weeks of Progressive Resistance Exercise or Relaxation Therapy. Ernberg M; Christidis N; Ghafouri B; Bileviciute-Ljungar I; Löfgren M; Bjersing J; Palstam A; Larsson A; Mannerkorpi K; Gerdle B; Kosek E Mediators Inflamm; 2018; 2018():3985154. PubMed ID: 29849487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]